Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?
| Status: | Withdrawn |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/18/2018 |
| Start Date: | August 23, 2017 |
| End Date: | January 1, 2018 |
To determine whether liposomal bupivacaine wound infiltration decreases pain scores and
narcotic use when compared to bupivacaine alone after open reduction internal fixation of
midshaft clavicle fractures.
narcotic use when compared to bupivacaine alone after open reduction internal fixation of
midshaft clavicle fractures.
Inclusion Criteria:
- Mid-shaft Clavicle Fracture treated with ORIF
Exclusion Criteria:
- Unable to be contacted for 72 hours post surgery
- Other concurrent surgical procedures
- Chronic narcotic user
We found this trial at
1
site
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials
